Cases & Deals

Purdue Pharma asserts patent infringement claims under Hatch-Waxman Act related to OxyContin® against Abhai

Clients Purdue Pharma L.P.

Jones Day successfully represented Purdue Pharma L.P. in a Hatch-Waxman patent infringement action against the defendant, Abhai LLC's, submission of an Abbreviated New Drug Application to the FDA seeking approval of generic versions of OxyContin®, a widely prescribed drug for pain relief.

Purdue Pharma LP et al. v. Abhai LLC et al., No. 1-17-cv-00450 (D. Del.)

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.